论文部分内容阅读
目前直肠癌的治疗仍以早期发现早期手术为主,但据有关资料统计,临床就诊患者中,20%~30%已属晚期,并且部分病人年纪较大,体质较弱,心肺储备又差,难于耐受手术治疗。部分低位直肠癌病人保肛愿望迫切,只能采取其他治疗方法,以提高生存质量,延长生存期。我科2007年3月~2015年03月共收治局部晚期低位直肠癌18例,采用卡培他滨(希罗达)联合放疗进行治疗,取得了较好的近期疗效,现总结报
At present, the treatment of rectal cancer is still mainly based on the early detection of early surgery. However, according to relevant statistics, 20% to 30% of clinical patients are already in advanced stage. Some patients are older, have weaker constitution, have poor cardiopulmonary reserve, Difficult to tolerate surgery. Part of the low rectal cancer patients desire an urgent protection, only to take other treatments to improve the quality of life and prolong survival. Our department from March 2007 to March 2015 were treated in 18 cases of locally advanced low rectal cancer, the use of capecitabine (Xeloda) combined with radiotherapy for treatment, and achieved good short-term efficacy, are now reported